As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers in the Department of Computer Science and Harvard Medical School could help predict new viral variants before they emerge.
A breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer brain injuries. The researchers demonstrated for the first time that neural cells can be 3D printed to mimic the architecture of the cerebral cortex.
The Focused Ultrasound Foundation has designated the University of Oxford a Centre of Excellence in Focused Ultrasound. Oxford becomes the fifth Centre of Excellence in Europe and the eleventh worldwide. The recognition coincides with the University of Oxford\u2019s celebration of Focused Ultrasound Day.
The new Fellows have been elected to the Academy in recognition of their exceptional contributions to the advancement of biomedical and health science, cutting edge research discoveries, and translating developments into benefits for patients and wider society.
DART (Dengue Advanced Readiness Tools) is a new, Oxford-led project involving scientists around the world, and one of 24 Wellcome-supported projects that will use climate data to better predict and prepare for infectious diseases outbreaks.
A new study led by researchers at the Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall.
A new study, involving researchers in the departments of Chemistry and Biochemistry and the Kavli Institute, sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armour, which has far-reaching implications for the development of antibiotics.
The Rockefeller Foundation has announced $3 million in new funding for Global.health (G.h) \u2013 a first-of-its-kind, open-source platform for scientific pandemic data.
Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK\u2019s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK teenagers.
Researchers from Oxford University\u2019s Department of Materials have developed a technique to precisely manipulate and place nanowires with sub-micron accuracy. This discovery could accelerate the development of even smaller and more powerful computer chips.
A new study involving Oxford's Department of Engineering Science has found that monitoring night-time blood pressure is important in preventing cardiovascular disease such as stroke or heart failure.
A team led by researchers from Oxford Chemistry have recently published a study in Nature Communications investigating the mechanism behind a resistance to the drug ivosidenib that has developed in some types of cancer.
Researchers at the Ineos Oxford Institute for Antimicrobial Resistance (IOI) and the Department of Biology have revealed links between the presence of bacteria that is resistant to antibiotics in mothers and their newborn babies, drawing on data from seven low- and middle-income countries in Africa and South Asia.
Oxford biologists are part of an international team that has been modelling the cancer-suppressing p53 gene to identify how 20 different molecules unique to elephants are activated for increased sensitivity and response against carcinogenic conditions \u2013 with implications for cancer treatments in humans.
Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.
Researchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in Parkinson\u2019s-like Multiple Systems Atrophy (MSA).
A \u00a311 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.
Scientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.
![\"Artist's](\"https://www.mpls.ox.ac.uk/latest/news/new-ai-tool-could-help-predict-viral-outbreaks/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n